Viewing data from:

ACYCLOVIR

ANDA

ACYCLOVIR | A075382 | CARLSBAD TECHNOLOGY INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 6 NDCs

Highest NADAC/Unit

$0.1965

per ea

Lowest NADAC/Unit

$0.0955

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
50268006215ACYCLOVIR 800 MG TABLET	$0.1965	EA	Generic	—	2026-10-21
61442011301ACYCLOVIR 800 MG TABLET	$0.1965	EA	Generic	—	2026-10-21
61442011305ACYCLOVIR 800 MG TABLET	$0.1965	EA	Generic	—	2026-10-21
50268006115ACYCLOVIR 400 MG TABLET	$0.0955	EA	Generic	—	2026-10-21
61442011201ACYCLOVIR 400 MG TABLET	$0.0955	EA	Generic	—	2026-10-21
61442011205ACYCLOVIR 400 MG TABLET	$0.0955	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs, 4 NC)

Lowest Price

$6.40

Highest Price

$57.29

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0145-01ACYCLOVIR 400MG TAB	$6.40	NC	Golden State Medical Supply, Inc.	03/10/2027
51407-0145-05ACYCLOVIR 400MG TAB	$30.55	NC	Golden State Medical Supply, Inc.	03/10/2027
51407-0146-01ACYCLOVIR 800MG TAB	$11.76	NC	Golden State Medical Supply, Inc.	03/10/2027
51407-0146-05ACYCLOVIR 800MG TAB	$57.29	NC	Golden State Medical Supply, Inc.	03/10/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain21 active DMFs16 inactive

18 active API suppliers hold Drug Master Files for this ingredient.

ATUL BIOSCIENCE LTDACYCLOVIR USP

DMF 415842025

QUIMICA SINTETICA SAACYCLOVIR

DMF 85841990

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAACYCLOVIR

DMF 100441993

OLON SPAACYCLOVIR

DMF 106851994

YUNG ZIP CHEMICAL IND CO LTDACYCLOVIR

DMF 108301994

UNION QUIMICO FARMACEUTICA SA (UQUIFA)ACYCLOVIR

DMF 118961996

MATRIX PHARMACORP PRIVATE LTDACYCLOVIR USP

DMF 132771998

TEVA PHARMACEUTICAL INDUSTRIES LTDACYCLOVIR

DMF 161442002

YUNG ZIP CHEMICAL IND CO LTDACYCLOVIR (PROCESS II)

DMF 199482006

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDACYCLOVIR USP (API)

DMF 202032007

OLON SPAACYCLOVIR

DMF 204452007

SIGNA SA DE CVACYCLOVIR USP

DMF 229492009

HUBEI YITAI PHARMACEUTICAL CO LTDACYCLOVIR (NON-STERILE, BULK FORM)

DMF 249192011

ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTDACYCLOVIR USP

DMF 249342011

PIRAMAL PHARMA LTDACYCLOVIR

DMF 253892011

HETERO DRUGS LTDACYCLOVIR

DMF 255872011

APEX HEALTHCARE LTDACYCLOVIR USP

DMF 420672025

AURORE LIFE SCIENCES PRIVATE LTDACYCLOVIR USP

DMF 345162020

HAINAN POLY PHARM CO LTDACYCLOVIR SODIUM DIHYDRATE DRUG SUBSTANCE

DMF 351122020

ZHEJIANG ZHEBEI PHARMACEUTICAL CO LTDACYCLOVIR

DMF 360712021

AURORE LIFE SCIENCES PRIVATE LTDACYCLOVIR USP [SITE KHAZIPALLY]

DMF 363282021

LACHEMA BRNOInactiveACYCLOVIR

DMF 95301992

OMNICHEM SAInactiveACYCLOVIR

DMF 101241993

CIPLA LTDInactiveACYCLOVIR

DMF 107101994

LEK LJUBLJANA PHARMACEUTICAL AND CHEMICAL COInactiveACYCLOVIR ACTIVE SUBSTANCE

DMF 113521995

FIDIA FARMACEUTICI SPAInactiveACYCLOVIR SODIUM SALT

DMF 118291996

MALLINCKRODT CHEMICAL INCInactiveACYCLOVIR, USP

DMF 119741996

ISTITUTO BIOLOGICO CHEMIOTERAPICO SPA DIVISIONE UNIBIOSInactiveACYCLOVIR

DMF 119811996

RANBAXY INCInactiveACYCLOVIR DRUG SUBSTANCE

DMF 121591996

TEVA GROUPInactiveACYCLOVIR USP

DMF 122091996

MALLINCKRODT CHEMICAL INCInactiveACYCLOVIR USP (MICRONIZED), CODED 2524

DMF 126211997

TEVA GROUPInactiveACYCLOVIR USP

DMF 146541999

SAMCHULLY PHARMACEUTICAL CO LTDInactiveACYCLOVIR DRUG SUBSTANCE

DMF 148652000

ASTRA IDL LTDInactiveACYCLOVIR USP, BULK

DMF 150992000

LIVZON GROUP CHANGZHOU KONY PHARMACEUTICAL CO LTDInactiveACYCLOVIR

DMF 175812004

QIDONG DONGYUE PHARMACEUTICAL CO LTDInactiveACYCLOVIR

DMF 266592012

PHARMACEUTICAL WORKS POLPHARMA SAInactiveACYCLOVIR

DMF 267872013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 30, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 400MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 30, 1999

No patent or exclusivity listings for this strength.

#002 — 800MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 30, 1999